Jonathan Rothbard

Dr Jonathan Rothbard works in the neurology department at Stanford University.

Dr Rothbard headed the Molecular Immunology Laboratory at the Imperial Cancer Research Fund in London in 1990, where he first worked with Professor Sir Marc Feldmann.

He has collaborated with Professor Lawrence Steinman since 1986, when they published the first of their 26 manuscripts together.

Dr Rothbard has been involved at a high level with start-up pharmaceuticals discovery; in 1987 he founded Amylin in San Diego and has also founded start-ups CellGate and ImmuLogic.

Amylin was focused on the discovery, development and commercialization of drugs treating diseases including diabetes and obesity.

The company was sold in 2012 to Bristol-Myers Squibb for $5.4 billion.

In addition to neurology, Dr Rothbard has also worked in the departments of chemistry and rheumatology at Stanford University.

Dr Rothbard holds a BA from Hamilton College and a PhD from Columbia University, which he followed with a fellowship at The Rockefeller University.